Go Pro
→ Trump is replacing the U.S. dollar (From Porter & Company) (Ad)tc pixel Free SRI Stock Alerts

Stoneridge (SRI) Financials

Stoneridge logo
$6.92 -0.01 (-0.13%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$6.94 +0.01 (+0.20%)
As of 07/2/2026 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Stoneridge

Annual Income Statements for Stoneridge

This table shows Stoneridge's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 23 77 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Consolidated Net Income / (Loss)		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Net Income / (Loss) Continuing Operations		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Total Pre-Tax Income 		20 39 53 65 68 -11 12 -11 -1.92 -14 -55
Total Operating Income		 28 44 57 67 71 -7.66 15 2.94 13 -0.38 -39
Total Gross Profit		 177 195 248 257 214 154 167 175 201 189 171
Total Revenue		 645 696 824 866 834 648 770 900 976 908 861
Operating Revenue		 645 696 824 866 834 648 770 900 976 908 861
Total Cost of Revenue		 468 501 576 610 621 494 604 725 775 719 690
Operating Cost of Revenue		 468 501 576 610 621 494 604 725 775 719 690
Total Operating Expenses		 149 151 191 190 142 162 151 172 188 190 210
Selling, General & Admin Expense		 110 111 142 139 124 112 116 107 117 117 126
Research & Development Expense		 39 40 49 51 52 49 66 65 71 72 63
Impairment Charge		 - - - - - - - - 0.00 0.00 22
Total Other Income / (Expense), net		 -7.59 -4.90 -4.79 -1.95 -2.89 -3.06 -2.98 -14 -15 -13 -17
Interest & Investment Income		 0.61 1.23 1.64 2.04 1.58 1.54 3.66 -7.92 -14 -16 -13
Other Income / (Expense), net		 -1.83 0.15 -0.64 0.74 -0.14 1.53 -1.44 -5.71 -1.24 2.52 -3.61
Income Tax Expense		 -0.55 -36 7.53 11 8.10 -2.77 9.03 3.36 3.26 2.93 47
Basic Earnings per Share		 $0.83 $2.79 $1.61 $1.90 $2.17 ($0.29) $0.13 ($0.52) ($0.19) ($0.60) ($3.70)
Weighted Average Basic Shares Outstanding		 27.34M 27.76M 28.08M 28.40M 27.79M 27.02M 27.11M 27.26M 27.44M 27.60M 27.80M
Diluted Earnings per Share		 $0.81 $2.74 $1.57 $1.85 $2.13 ($0.29) $0.12 ($0.52) ($0.19) ($0.60) ($3.70)
Weighted Average Diluted Shares Outstanding		 27.96M 28.31M 28.77M 29.08M 28.27M 27.02M 27.42M 27.26M 27.44M 27.60M 27.80M
Weighted Average Basic & Diluted Shares Outstanding		 27.40M 27.80M 28.10M 28.30M 27.80M 27.01M 27.19M 27.35M 27.55M 27.70M 28.02M

Quarterly Income Statements for Stoneridge

This table shows Stoneridge's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 2.17 3.02 -6.13 2.79 -7.07 -6.11 -7.20 -9.36 -9.37 -77 -28
Consolidated Net Income / (Loss)		 2.17 3.02 -6.13 2.79 -7.07 -6.11 -7.20 -9.36 -9.37 -77 -28
Net Income / (Loss) Continuing Operations		 2.17 3.02 -6.13 2.79 -7.07 -6.11 -8.00 -9.36 -9.37 -77 -15
Total Pre-Tax Income 		4.44 3.24 -5.62 1.85 -3.66 -6.17 -6.43 -9.12 -9.71 -31 -13
Total Operating Income		 6.51 6.02 0.33 3.41 0.32 -4.43 -4.31 -2.60 -3.28 -30 -8.98
Total Gross Profit		 52 46 48 54 44 43 35 49 43 33 35
Total Revenue		 238 230 239 237 214 218 149 228 210 205 161
Operating Revenue		 238 230 239 237 214 218 149 228 210 205 161
Total Cost of Revenue		 186 184 191 183 169 176 114 179 167 172 126
Operating Cost of Revenue		 186 184 191 183 169 176 114 179 167 172 126
Total Operating Expenses		 46 40 48 50 44 47 40 52 46 63 44
Selling, General & Admin Expense		 28 26 30 32 27 29 26 33 32 29 33
Research & Development Expense		 18 14 18 18 18 18 14 19 14 12 11
Total Other Income / (Expense), net		 -2.07 -2.79 -5.95 -1.56 -3.97 -1.74 -2.12 -6.51 -6.44 -1.49 -4.39
Interest & Investment Income		 -3.45 -6.45 -3.91 -3.85 -4.36 -7.25 -2.95 -3.08 -4.02 -3.26 -3.92
Other Income / (Expense), net		 1.38 0.92 -2.04 2.30 0.38 1.88 0.83 -3.43 -2.41 1.77 -0.47
Income Tax Expense		 2.27 0.21 0.51 -0.94 3.41 -0.06 1.58 0.24 -0.34 46 1.41
Net Income / (Loss) Discontinued Operations		 - - - - - - 0.81 - - - -13
Basic Earnings per Share		 $0.08 $0.11 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00)
Weighted Average Basic Shares Outstanding		 27.48M 27.44M 27.53M 27.61M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M
Diluted Earnings per Share		 $0.08 $0.11 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00)
Weighted Average Diluted Shares Outstanding		 27.73M 27.44M 27.53M 27.85M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M
Weighted Average Basic & Diluted Shares Outstanding		 27.55M 27.55M 27.67M 27.68M 27.69M 27.70M 27.85M 28.01M 28.02M 28.02M 28.24M

Annual Cash Flow Statements for Stoneridge

This table details how cash moves in and out of Stoneridge's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 11 -3.97 16 19 -12 4.52 12 -31 -14 31 -5.58
Net Cash From Operating Activities		 55 65 79 81 25 29 -36 6.81 4.95 48 34
Net Cash From Continuing Operating Activities		 55 65 79 81 25 29 -36 6.81 4.95 48 34
Net Income / (Loss) Continuing Operations		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Consolidated Net Income / (Loss)		 21 76 45 54 60 -7.95 3.41 -14 -5.18 -17 -103
Depreciation Expense		 19 20 21 23 25 27 28 27 27 26 24
Amortization Expense		 3.83 3.62 6.76 6.73 6.58 5.93 6.65 8.06 8.13 8.85 9.96
Non-Cash Adjustments To Reconcile Net Income		 6.90 3.97 2.98 2.55 -30 6.89 -32 7.07 3.21 5.89 27
Changes in Operating Assets and Liabilities, net		 4.54 -38 2.63 -5.14 -37 -3.48 -42 -21 -28 23 76
Net Cash From Investing Activities		 -30 -24 -109 -28 -6.30 -34 28 -29 -37 -24 -22
Net Cash From Continuing Investing Activities		 -30 -24 -109 -28 -6.30 -34 28 -29 -37 -24 -22
Purchase of Property, Plant & Equipment		 -29 -24 -32 -29 -39 -32 -27 -32 -38 -24 -22
Acquisitions		 -1.70 - -77 - - - - -0.95 -0.35 -0.55 -0.37
Sale of Property, Plant & Equipment		 0.06 0.65 0.08 0.11 0.38 0.13 0.27 0.16 1.87 0.39 0.40
Net Cash From Financing Activities		 -11 -43 41 -34 -28 6.51 23 -7.30 17 11 -25
Net Cash From Continuing Financing Activities		 -11 -43 41 -34 -28 6.51 23 -7.30 17 11 -25
Repayment of Debt		 -31 -59 -53 -58 -85 -99 -112 -61 -134 -155 -94
Issuance of Debt		 23 16 98 28 114 113 138 61 153 167 69
Other Financing Activities, net		 -2.92 -0.45 -2.48 -4.21 -7.51 -1.77 -2.67 -7.07 -1.72 -0.80 -0.34
Effect of Exchange Rate Changes		 -2.08 -2.05 4.56 - -1.64 3.25 -3.04 - - - 7.52
Cash Interest Paid		 6.09 5.79 5.75 5.00 4.40 5.62 6.06 7.29 13 15 14
Cash Income Taxes Paid		 2.49 3.39 7.09 13 12 -0.25 11 6.18 10 9.26 10

Quarterly Cash Flow Statements for Stoneridge

This table details how cash moves in and out of Stoneridge's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 2.05 4.08 7.60 -6.33 12 18 7.28 -29 4.22 12 17
Net Cash From Operating Activities		 -0.98 11 9.11 8.65 11 19 10 11 3.60 8.83 -11
Net Cash From Continuing Operating Activities		 -0.98 11 9.11 8.65 11 19 10 11 3.60 8.83 -11
Net Income / (Loss) Continuing Operations		 2.17 3.02 -6.13 2.79 -7.07 -6.11 -8.00 -9.36 -9.37 -77 -25
Consolidated Net Income / (Loss)		 2.17 3.02 -6.13 2.79 -7.07 -6.11 -7.20 -9.36 -9.37 -77 -28
Net Income / (Loss) Discontinued Operations		 - - - - - - 0.81 - - - -3.32
Depreciation Expense		 6.64 6.95 6.60 6.45 6.64 6.45 5.43 5.35 7.19 5.76 3.43
Amortization Expense		 2.07 2.06 2.16 2.28 2.37 2.04 2.05 2.49 2.58 2.83 2.78
Non-Cash Adjustments To Reconcile Net Income		 1.14 1.09 1.87 1.17 1.66 1.20 1.29 1.46 1.35 23 14
Changes in Operating Assets and Liabilities, net		 -13 -2.50 4.61 -4.03 7.15 16 9.33 11 1.86 55 -6.79
Net Cash From Investing Activities		 -11 -10 -5.71 -7.24 -6.04 -5.47 -5.99 -3.23 -6.37 -6.24 58
Net Cash From Continuing Investing Activities		 -11 -10 -5.71 -7.24 -6.04 -5.47 -5.99 -3.23 -6.37 -6.24 58
Purchase of Property, Plant & Equipment		 -11 -9.91 -5.80 -7.13 -6.13 -5.25 -6.07 -3.28 -6.30 -6.20 -0.84
Sale of Property, Plant & Equipment		 0.11 0.03 0.08 0.14 0.09 0.07 0.08 0.14 0.11 0.06 0.23
Divestitures		 - - - - - - 0.00 - - - 59
Net Cash From Financing Activities		 15 1.95 5.39 -7.07 5.81 6.99 -0.79 -41 6.72 9.34 -25
Net Cash From Continuing Financing Activities		 15 1.95 5.39 -7.07 5.81 6.99 -0.79 -41 6.72 9.34 -25
Repayment of Debt		 -36 -42 -32 -43 -42 -38 -7.26 -65 -13 -8.17 -48
Issuance of Debt		 51 44 38 36 23 45 6.70 25 4.70 33 22
Other Financing Activities, net		 -0.37 -0.02 -0.62 -0.05 -0.11 -0.02 -0.23 -0.08 -0.04 - -0.01
Effect of Exchange Rate Changes		 - - - - - -3.05 3.16 3.78 0.26 0.33 -0.61
Other Net Changes in Cash		 - 1.55 -1.18 -0.67 1.50 - 0.81 - - - -3.32
Cash Interest Paid		 3.63 3.76 4.19 3.81 3.89 3.57 3.38 3.40 4.00 3.46 4.38

Annual Balance Sheets for Stoneridge

This table presents Stoneridge's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 364 395 559 560 602 621 665 652 680 622 551
Total Current Assets		 232 241 303 320 331 335 411 410 429 388 362
Cash & Equivalents		 54 50 66 81 69 74 86 55 41 72 53
Accounts Receivable		 95 113 142 139 139 137 150 158 167 138 89
Inventories, net		 61 60 73 79 93 91 138 153 188 151 106
Prepaid Expenses		 22 17 21 21 30 33 37 44 34 27 27
Other Current Nonoperating Assets		 - - - - - - - - - - 86
Plant, Property, & Equipment, net		 85 92 110 112 122 119 108 105 110 98 63
Total Noncurrent Assets		 47 62 145 127 148 167 147 138 140 136 127
Long-Term Investments		 10 22 32 28 32 54 42 44 47 54 22
Goodwill		 37 0.93 38 37 36 39 36 34 35 33 38
Intangible Assets		 - 39 75 62 58 55 50 46 47 40 38
Other Noncurrent Operating Assets		 - - - 0.00 22 19 18 14 11 10 9.57
Other Noncurrent Nonoperating Assets		 - - - - - - - - - - 20
Total Liabilities & Shareholders' Equity		 364 395 559 560 602 621 665 652 680 622 551
Total Liabilities		 258 202 315 276 312 325 369 371 392 376 371
Total Current Liabilities		 108 113 136 147 139 146 173 178 178 150 157
Accounts Payable		 55 63 79 88 81 86 98 110 112 83 62
Accrued Expenses		 - - - - - - - - - - 65
Other Current Nonoperating Liabilities		 - - - - - - - - - - 30
Total Noncurrent Liabilities		 150 90 179 129 174 179 196 193 214 226 214
Long-Term Debt		 4.46 8.06 3.85 0.98 0.45 - - 168 189 202 181
Noncurrent Deferred & Payable Income Tax Liabilities		 41 9.76 19 15 13 13 11 8.50 7.22 5.32 9.97
Other Noncurrent Operating Liabilities		 104 72 156 113 161 166 186 17 17 19 18
Other Noncurrent Nonoperating Liabilities		 - - - - - - - - - - 4.73
Total Equity & Noncontrolling Interests		 106 192 244 283 290 297 296 281 288 245 180
Total Preferred & Common Equity		 93 178 244 283 290 297 296 281 288 245 180
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 93 178 244 283 290 297 296 281 288 245 180
Common Stock		 199 207 228 232 226 234 232 233 227 226 219
Retained Earnings		 -32 45 92 146 207 212 216 202 197 180 77
Treasury Stock		 -4.21 -5.63 -7.12 -8.88 -51 -60 -55 -50 -43 -38 -27
Accumulated Other Comprehensive Income / (Loss)		 -70 -68 -70 -86 -91 -90 -97 -103 -93 -122 -89

Quarterly Balance Sheets for Stoneridge

This table presents Stoneridge's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 679 675 667 663 657 639 632 512
Total Current Assets		 436 431 422 414 418 393 384 348
Cash & Equivalents		 37 48 42 54 79 50 54 71
Accounts Receivable		 177 170 168 159 157 163 153 140
Inventories, net		 183 180 179 176 152 144 145 111
Prepaid Expenses		 39 33 33 25 30 36 32 26
Other Current Nonoperating Assets		 - - - - - - - 0.00
Plant, Property, & Equipment, net		 107 106 103 103 99 100 100 60
Total Noncurrent Assets		 136 138 142 145 140 146 147 104
Long-Term Investments		 45 49 55 54 55 54 56 22
Goodwill		 34 34 34 36 35 38 38 37
Intangible Assets		 45 45 44 44 41 43 41 36
Other Noncurrent Operating Assets		 11 9.55 8.72 11 9.61 11 13 9.02
Other Noncurrent Nonoperating Assets		 - - - - - - - 0.00
Total Liabilities & Shareholders' Equity		 679 675 667 663 657 639 632 512
Total Liabilities		 405 398 396 391 404 379 381 356
Total Current Liabilities		 382 180 186 170 175 184 180 173
Accounts Payable		 131 109 108 98 97 106 102 103
Accrued Expenses		 - - - - - - - 69
Other Current Nonoperating Liabilities		 - - - - - - - 0.00
Total Noncurrent Liabilities		 24 218 210 221 229 195 201 183
Long-Term Debt		 0.00 194 187 196 203 164 170 156
Noncurrent Deferred & Payable Income Tax Liabilities		 7.41 6.85 6.28 6.34 5.34 5.37 4.94 8.73
Other Noncurrent Operating Liabilities		 16 17 16 19 21 25 26 18
Other Noncurrent Nonoperating Liabilities		 - - - - - - - 0.00
Total Equity & Noncontrolling Interests		 273 277 270 271 253 261 251 156
Total Preferred & Common Equity		 273 277 270 271 253 261 251 156
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 273 277 270 271 253 261 251 156
Common Stock		 226 224 225 225 221 218 218 216
Retained Earnings		 193 190 193 186 173 163 154 49
Treasury Stock		 -43 -39 -39 -39 -33 -28 -27 -20
Accumulated Other Comprehensive Income / (Loss)		 -103 -98 -108 -101 -108 -92 -93 -88

Annual Metrics And Ratios for Stoneridge

This table displays calculated financial ratios and metrics derived from Stoneridge's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 27,911,948.00 27,842,883.00 28,171,209.00 28,484,466.00 27,403,031.00 27,005,257.00 27,178,466.00 27,326,558.00 27,547,977.00 - 28,016,931.00
DEI Adjusted Shares Outstanding		 27,911,948.00 27,842,883.00 28,171,209.00 28,484,466.00 27,403,031.00 27,005,257.00 27,178,466.00 27,326,558.00 27,547,977.00 - 28,016,931.00
DEI Earnings Per Adjusted Shares Outstanding		 0.82 2.78 1.60 1.89 2.20 -0.29 0.13 -0.51 -0.19 - -3.67
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -2.39% 7.93% 18.46% 5.06% -3.68% -22.33% 18.90% 16.80% 8.43% -6.92% -5.18%
EBITDA Growth		 1,220.99% 39.07% 25.27% 14.44% 5.52% -73.59% 78.74% -33.94% 45.26% -20.11% -122.97%
EBIT Growth		 198.48% 70.20% 28.26% 19.41% 5.02% -108.63% 327.62% -119.88% 517.87% -81.53% -2,070.78%
NOPAT Growth		 258.04% 197.61% -42.19% 12.83% 13.30% -108.54% 178.68% -51.32% 337.34% -102.97% -10,032.81%
Net Income Growth		 133.94% 267.45% -40.39% 19.53% 11.97% -113.19% 142.84% -512.68% 63.13% -218.81% -522.34%
EPS Growth		 146.29% 238.27% -42.70% 17.83% 15.14% -113.62% 141.38% -533.33% 63.46% -215.79% -516.67%
Operating Cash Flow Growth		 176.58% 19.11% 20.88% 2.36% -69.66% 16.88% -226.56% 118.78% -27.33% 865.39% -28.75%
Free Cash Flow Firm Growth		 -58.82% -85.45% 259.59% 8.32% 42.48% -80.37% -25.01% -2,583.51% 82.10% 321.88% 15.26%
Invested Capital Growth		 -33.92% 127.19% 13.25% 14.11% 8.44% -7.73% -1.61% 102.21% 11.50% -17.86% -33.38%
Revenue Q/Q Growth		 -1.85% 2.65% 4.41% 0.39% -2.39% -0.10% 1.84% 3.15% -0.17% -1.23% -1.50%
EBITDA Q/Q Growth		 111.43% 7.45% 6.66% -0.62% -10.09% 24.71% -18.81% 36.71% 9.93% -21.24% -151.57%
EBIT Q/Q Growth		 2,160.82% 8.43% 7.97% -0.88% -14.84% 42.52% -44.15% 76.55% 44.96% -81.59% -147.76%
NOPAT Q/Q Growth		 1,334.05% 118.69% -40.94% -11.87% -9.66% 37.51% -73.80% 139.38% 0.30% -103.78% -185.15%
Net Income Q/Q Growth		 218.32% 135.90% -39.64% -11.29% -11.52% -8.59% -74.10% 31.26% 35.05% -123.72% -220.96%
EPS Q/Q Growth		 302.50% 119.20% -40.30% -11.48% -10.88% -3.57% -75.00% 29.73% 36.67% -122.22% -218.97%
Operating Cash Flow Q/Q Growth		 45.01% -12.60% -0.59% 7.08% -54.33% 121.37% -1,208,166.67% 116.72% -80.43% 22.02% -23.41%
Free Cash Flow Firm Q/Q Growth		 -60.27% -60.33% 69.83% -24.53% -20.85% -44.84% 153.39% -26,315.50% 82.34% 181.79% 116.14%
Invested Capital Q/Q Growth		 -27.90% 35.90% -6.54% -4.00% -0.74% 5.66% -11.58% 84.33% 3.78% -10.57% -31.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 27.45% 28.08% 30.10% 29.63% 25.62% 23.80% 21.66% 19.44% 20.63% 20.84% 19.87%
EBITDA Margin		 7.57% 9.75% 10.31% 11.23% 12.30% 4.18% 6.29% 3.56% 4.76% 4.09% -0.99%
Operating Margin		 4.31% 6.33% 6.96% 7.74% 8.54% -1.18% 2.00% 0.33% 1.32% -0.04% -4.48%
EBIT Margin		 4.03% 6.36% 6.88% 7.82% 8.53% -0.95% 1.81% -0.31% 1.19% 0.24% -4.90%
Profit (Net Income) Margin		 3.19% 10.86% 5.46% 6.22% 7.23% -1.23% 0.44% -1.56% -0.53% -1.82% -11.94%
Tax Burden Percent		 101.67% 192.86% 85.67% 82.77% 88.15% 74.13% 27.39% 131.41% 269.67% 121.53% 185.45%
Interest Burden Percent		 77.85% 88.60% 92.69% 96.04% 96.14% 174.77% 89.04% 385.30% -16.57% -634.78% 131.36%
Effective Tax Rate		 -2.70% -92.86% 14.33% 17.23% 11.85% 0.00% 72.61% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 37.86% 86.54% 33.79% 33.53% 34.20% -2.92% 2.41% 0.78% 2.42% -0.07% -10.09%
ROIC Less NNEP Spread (ROIC-NNEP)		 60.94% 105.06% 39.44% 35.17% 36.67% -0.56% 3.08% 62.34% -13.89% -18.16% -147.25%
Return on Net Nonoperating Assets (RNNOA)		 -19.18% -35.91% -13.13% -13.11% -13.16% 0.21% -1.26% -5.66% -4.24% -6.13% -38.30%
Return on Equity (ROE)		 18.68% 50.63% 20.66% 20.42% 21.04% -2.71% 1.15% -4.87% -1.82% -6.20% -48.39%
Cash Return on Invested Capital (CROIC)		 78.70% 8.80% 21.36% 20.35% 26.10% 5.12% 4.04% -66.86% -8.46% 19.54% 29.98%
Operating Return on Assets (OROA)		 6.81% 11.66% 11.90% 12.11% 12.25% -1.00% 2.17% -0.42% 1.74% 0.33% -7.20%
Return on Assets (ROA)		 5.39% 19.92% 9.45% 9.63% 10.38% -1.30% 0.53% -2.13% -0.78% -2.54% -17.54%
Return on Common Equity (ROCE)		 15.64% 46.04% 20.01% 20.42% 21.04% -2.71% 1.15% -4.87% -1.82% -6.20% -48.39%
Return on Equity Simple (ROE_SIMPLE)		 22.09% 42.38% 18.46% 19.01% 20.80% -2.68% 1.15% -5.00% 0.00% -6.74% 0.00%
Net Operating Profit after Tax (NOPAT)		 29 85 49 55 63 -5.36 4.22 2.05 8.99 -0.27 -27
NOPAT Margin		 4.43% 12.22% 5.96% 6.40% 7.53% -0.83% 0.55% 0.23% 0.92% -0.03% -3.14%
Net Nonoperating Expense Percent (NNEP)		 -23.09% -18.51% -5.65% -1.64% -2.48% -2.36% -0.67% -61.56% 16.32% 18.08% 137.16%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 0.46% 1.88% -0.06% -7.49%
Cost of Revenue to Revenue		 72.55% 71.92% 69.90% 70.37% 74.38% 76.20% 78.34% 80.56% 79.37% 79.16% 80.13%
SG&A Expenses to Revenue		 17.12% 15.97% 17.21% 16.00% 14.85% 17.36% 15.06% 11.86% 12.03% 12.93% 14.58%
R&D to Revenue		 6.02% 5.78% 5.93% 5.90% 6.26% 7.62% 8.59% 7.26% 7.28% 7.95% 7.26%
Operating Expenses to Revenue		 23.13% 21.75% 23.14% 21.89% 17.07% 24.98% 19.66% 19.11% 19.31% 20.88% 24.35%
Earnings before Interest and Taxes (EBIT)		 26 44 57 68 71 -6.14 14 -2.78 12 2.14 -42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 49 68 85 97 103 27 48 32 46 37 -8.53
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.44 2.76 2.64 2.48 2.77 2.75 1.81 2.10 1.87 0.71 0.90
Price to Tangible Book Value (P/TBV)		 7.32 3.57 4.94 3.81 4.10 4.04 2.56 2.93 2.63 1.01 1.55
Price to Revenue (P/Rev)		 0.64 0.71 0.78 0.81 0.96 1.26 0.70 0.65 0.55 0.19 0.19
Price to Earnings (P/E)		 18.14 6.36 14.25 13.04 13.33 0.00 157.52 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.51% 15.73% 7.02% 7.67% 7.50% 0.00% 0.63% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 6.33 3.30 3.59 3.38 3.69 3.95 2.39 1.88 1.64 0.78 1.25
Enterprise Value to Revenue (EV/Rev)		 0.59 0.65 0.67 0.69 0.84 1.07 0.54 0.73 0.66 0.28 0.31
Enterprise Value to EBITDA (EV/EBITDA)		 7.79 6.64 6.52 6.12 6.87 25.69 8.55 20.60 13.83 6.73 0.00
Enterprise Value to EBIT (EV/EBIT)		 14.62 10.19 9.77 8.79 9.91 0.00 29.65 0.00 55.41 116.61 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 13.30 5.30 11.28 10.73 11.22 0.00 98.11 320.86 71.53 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.93 6.90 7.03 7.37 28.76 24.31 0.00 96.86 129.95 5.23 7.88
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.40 52.16 17.84 17.68 14.70 73.94 58.65 0.00 0.00 3.59 3.34
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.17 0.09 0.03 0.01 0.01 0.03 0.02 0.60 0.67 0.82 1.01
Long-Term Debt to Equity		 0.04 0.04 0.02 0.00 0.00 0.00 0.00 0.60 0.66 0.82 1.01
Financial Leverage		 -0.31 -0.34 -0.33 -0.37 -0.36 -0.37 -0.41 -0.09 0.31 0.34 0.26
Leverage Ratio		 3.46 2.54 2.19 2.12 2.03 2.09 2.17 2.28 2.34 2.44 2.76
Compound Leverage Factor		 2.70 2.25 2.03 2.04 1.95 3.65 1.93 8.80 -0.39 -15.50 3.62
Debt to Total Capital		 14.71% 7.99% 3.19% 0.88% 1.07% 2.52% 1.74% 37.60% 39.96% 45.11% 50.16%
Short-Term Debt to Total Capital		 11.14% 4.13% 1.66% 0.54% 0.91% 2.52% 1.74% 0.32% 0.44% 0.00% 0.00%
Long-Term Debt to Total Capital		 3.57% 3.86% 1.53% 0.34% 0.15% 0.00% 0.00% 37.27% 39.51% 45.11% 50.16%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 10.67% 6.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 74.62% 85.42% 96.81% 99.12% 98.93% 97.48% 98.26% 62.40% 60.04% 54.89% 49.84%
Debt to EBITDA		 0.38 0.25 0.09 0.03 0.03 0.28 0.11 5.29 4.12 5.43 -21.22
Net Debt to EBITDA		 -0.95 -0.82 -1.05 -1.10 -0.96 -4.44 -2.53 2.19 2.23 2.05 -12.40
Long-Term Debt to EBITDA		 0.09 0.12 0.05 0.01 0.00 0.00 0.00 5.24 4.07 5.43 -21.22
Debt to NOPAT		 0.64 0.20 0.16 0.05 0.05 -1.43 1.24 82.38 21.31 -755.82 -6.70
Net Debt to NOPAT		 -1.62 -0.65 -1.82 -1.93 -1.57 22.41 -28.99 34.09 11.53 -285.65 -3.91
Long-Term Debt to NOPAT		 0.16 0.09 0.08 0.02 0.01 0.00 0.00 81.68 21.07 -755.82 -6.70
Altman Z-Score		 3.25 4.14 3.63 4.21 4.18 3.36 2.98 3.18 3.16 2.61 2.21
Noncontrolling Interest Sharing Ratio		 16.28% 9.07% 3.16% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.15 2.14 2.23 2.17 2.39 2.29 2.37 2.30 2.41 2.58 2.30
Quick Ratio		 1.38 1.45 1.53 1.49 1.50 1.44 1.36 1.20 1.16 1.40 0.90
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 59 8.64 31 34 48 9.42 7.06 -175 -31 70 80
Operating Cash Flow to CapEx		 191.15% 274.00% 245.87% 279.33% 62.70% 88.58% -135.44% 21.64% 13.50% 199.63% 158.60%
Free Cash Flow to Firm to Interest Expense		 9.33 1.38 5.37 7.13 11.09 1.54 1.36 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 8.61 10.40 13.64 17.11 5.67 4.68 -6.99 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 4.11 6.60 8.10 10.99 -3.37 -0.60 -12.14 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.69 1.83 1.73 1.55 1.44 1.06 1.20 1.37 1.47 1.40 1.47
Accounts Receivable Turnover		 6.45 6.69 6.45 6.15 6.01 4.71 5.37 5.83 6.01 5.97 7.60
Inventory Turnover		 7.07 8.26 8.63 7.98 7.19 5.37 5.28 4.99 4.55 4.24 5.35
Fixed Asset Turnover		 7.56 7.87 8.17 7.78 7.11 5.36 6.78 8.47 9.09 8.74 10.74
Accounts Payable Turnover		 8.22 8.50 8.12 7.29 7.36 5.92 6.57 6.98 6.97 7.36 9.46
Days Sales Outstanding (DSO)		 56.62 54.58 56.59 59.31 60.73 77.54 68.01 62.57 60.73 61.14 48.06
Days Inventory Outstanding (DIO)		 51.59 44.16 42.30 45.73 50.80 68.00 69.14 73.18 80.19 86.07 68.16
Days Payable Outstanding (DPO)		 44.40 42.96 44.96 50.08 49.58 61.65 55.57 52.33 52.34 49.60 38.58
Cash Conversion Cycle (CCC)		 63.81 55.79 53.94 54.96 61.95 83.89 81.58 83.42 88.58 97.61 77.64
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 60 136 155 176 191 176 174 351 391 321 214
Invested Capital Turnover		 8.54 7.08 5.67 5.24 4.54 3.53 4.40 3.43 2.63 2.55 3.22
Increase / (Decrease) in Invested Capital		 -31 76 18 22 15 -15 -2.84 177 40 -70 -107
Enterprise Value (EV)		 380 451 554 595 705 696 414 659 643 250 268
Market Capitalization		 413 493 644 702 803 816 537 589 539 174 162
Book Value per Share		 $3.34 $6.40 $8.66 $9.94 $10.58 $10.98 $10.89 $10.28 $10.44 $8.86 $6.42
Tangible Book Value per Share		 $2.02 $4.96 $4.63 $6.48 $7.15 $7.49 $7.72 $7.36 $7.45 $6.23 $3.73
Total Capital		 125 209 252 286 293 304 301 450 479 447 361
Total Debt		 18 17 8.04 2.52 3.13 7.67 5.25 169 191 202 181
Total Long-Term Debt		 4.46 8.06 3.85 0.98 0.45 0.00 0.00 168 189 202 181
Net Debt		 -46 -56 -90 -107 -99 -120 -122 70 104 76 106
Capital Expenditures (CapEx)		 29 24 32 29 39 32 27 31 37 24 21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 83 86 105 93 126 122 157 179 212 166 151
Debt-free Net Working Capital (DFNWC)		 138 137 171 174 195 196 243 233 253 238 204
Net Working Capital (NWC)		 124 128 167 173 193 189 238 232 251 238 204
Net Nonoperating Expense (NNE)		 8.00 9.44 4.10 1.61 2.55 2.59 0.81 16 14 16 76
Net Nonoperating Obligations (NNO)		 -46 -56 -90 -107 -99 -120 -122 70 104 76 34
Total Depreciation and Amortization (D&A)		 23 24 28 30 31 33 34 35 35 35 34
Debt-free, Cash-free Net Working Capital to Revenue		 12.93% 12.42% 12.79% 10.77% 15.10% 18.88% 20.44% 19.84% 21.77% 18.24% 17.56%
Debt-free Net Working Capital to Revenue		 21.37% 19.66% 20.79% 20.13% 23.41% 30.29% 31.54% 25.93% 25.95% 26.15% 23.72%
Net Working Capital to Revenue		 19.21% 18.42% 20.29% 19.96% 23.09% 29.11% 30.86% 25.76% 25.74% 26.15% 23.72%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.83 $2.79 $1.61 $1.90 $2.17 ($0.29) $0.13 ($0.52) ($0.19) ($0.60) ($3.70)
Adjusted Weighted Average Basic Shares Outstanding		 27.34M 27.76M 28.08M 28.40M 27.79M 27.02M 27.11M 27.26M 27.44M 27.60M 27.80M
Adjusted Diluted Earnings per Share		 $0.81 $2.74 $1.57 $1.85 $2.13 ($0.29) $0.12 ($0.52) ($0.19) ($0.60) ($3.70)
Adjusted Weighted Average Diluted Shares Outstanding		 27.96M 28.31M 28.77M 29.08M 28.27M 27.02M 27.42M 27.26M 27.44M 27.60M 27.80M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $2.17 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.79M 27.87M 28.18M 28.49M 27.41M 27.01M 27.19M 27.35M 27.55M 27.70M 28.02M
Normalized Net Operating Profit after Tax (NOPAT)		 19 31 49 55 33 -5.36 -11 2.05 8.99 -0.27 -12
Normalized NOPAT Margin		 3.02% 4.43% 5.96% 6.40% 3.98% -0.83% -1.39% 0.23% 0.92% -0.03% -1.38%
Pre Tax Income Margin		 3.14% 5.63% 6.38% 7.51% 8.20% -1.65% 1.61% -1.19% -0.20% -1.50% -6.44%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.08 7.05 9.81 14.35 16.45 -1.00 2.69 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 4.49 13.54 8.50 11.75 14.53 -0.88 0.81 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -0.42 3.25 4.26 8.23 7.41 -6.28 -2.47 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -0.02 9.75 2.95 5.62 5.49 -6.16 -4.34 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 4.10% 0.00% 82.93% -62.83% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Stoneridge

This table displays calculated financial ratios and metrics derived from Stoneridge's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 27,521,833.00 27,547,977.00 27,553,610.00 27,671,231.00 27,677,748.00 - 27,695,248.00 27,846,292.00 28,006,494.00 28,016,931.00 28,016,931.00
DEI Adjusted Shares Outstanding		 27,521,833.00 27,547,977.00 27,553,610.00 27,671,231.00 27,677,748.00 - 27,695,248.00 27,846,292.00 28,006,494.00 28,016,931.00 28,016,931.00
DEI Earnings Per Adjusted Shares Outstanding		 0.08 0.11 -0.22 0.10 -0.26 - -0.26 -0.34 -0.33 -2.75 -1.00
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 5.03% -0.72% -0.90% -11.15% -10.22% -4.91% -37.67% -3.84% -1.67% -6.00% 7.91%
EBITDA Growth		 38.85% 35.73% 111.25% 36.28% -41.52% -62.80% -43.33% -87.46% -58.06% -422.66% -180.93%
EBIT Growth		 123.59% 107.72% 67.07% 193.36% -91.15% -136.83% -104.16% -205.75% -914.45% -985.36% -171.42%
NOPAT Growth		 27.76% 186.68% 108.22% 69.24% -93.07% -155.15% -1,400.91% -135.49% -1,140.95% -565.34% -108.50%
Net Income Growth		 196.99% 1,232.16% 17.06% 193.12% -425.66% -302.18% -17.47% -435.93% -32.55% -1,157.92% -287.95%
EPS Growth		 166.67% 0.00% 18.52% 190.91% -425.00% -300.00% -18.18% -440.00% -30.77% -1,154.55% -284.62%
Operating Cash Flow Growth		 84.49% -65.70% 199.21% 92.55% 1,197.45% 81.19% 10.76% 23.55% -66.49% -54.08% -213.98%
Free Cash Flow Firm Growth		 -2,290.30% 80.19% -1,286.61% 105.83% 109.75% 292.27% 128.34% 301.68% 147.84% 29.70% 88.72%
Invested Capital Growth		 98.04% 11.50% 92.09% -1.32% -4.68% -17.86% -14.37% -11.54% -12.97% -33.38% -31.85%
Revenue Q/Q Growth		 -10.74% -3.63% 4.20% -0.88% -9.80% 2.07% -31.70% 4.62% -7.76% -2.43% -21.60%
EBITDA Q/Q Growth		 56.82% -4.00% -55.71% 104.42% -32.71% -38.94% -32.53% -61.68% 125.03% -569.78% 83.08%
EBIT Q/Q Growth		 306.12% -12.12% -124.57% 434.49% -87.74% -465.52% -36.24% -118.59% 5.60% -387.11% 65.93%
NOPAT Q/Q Growth		 5.00% 76.77% -95.88% 2,114.40% -95.70% -1,507.62% 2.89% 19.35% -26.07% -799.70% 69.57%
Net Income Q/Q Growth		 172.56% 39.29% -302.58% 145.48% -353.77% 13.52% -17.70% -30.06% -0.13% -720.71% 63.70%
EPS Q/Q Growth		 172.73% 37.50% -300.00% 145.45% -360.00% 15.38% -18.18% -30.77% 0.00% -711.76% 63.77%
Operating Cash Flow Q/Q Growth		 -121.81% 1,183.06% -14.18% -5.01% 24.29% 78.81% -47.54% -1.89% -66.29% 145.01% -230.23%
Free Cash Flow Firm Q/Q Growth		 -7.26% 81.06% -419.10% 105.53% 79.43% 273.58% -23.50% -22.81% 10.71% 95.50% 11.31%
Invested Capital Q/Q Growth		 2.59% 3.78% -3.74% -3.71% -0.91% -10.57% 0.36% -0.53% -2.52% -31.54% 2.67%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 22.03% 19.84% 20.22% 22.67% 20.81% 19.55% 23.65% 21.47% 20.34% 16.16% 21.73%
EBITDA Margin		 6.97% 6.95% 2.95% 6.09% 4.54% 2.72% 2.68% 0.79% 1.94% -9.33% -2.01%
Operating Margin		 2.73% 2.62% 0.14% 1.44% 0.15% -2.03% -2.89% -1.14% -1.56% -14.38% -5.58%
EBIT Margin		 3.31% 3.02% -0.71% 2.41% 0.33% -1.17% -2.34% -2.65% -2.71% -13.52% -5.87%
Profit (Net Income) Margin		 0.91% 1.32% -2.56% 1.18% -3.31% -2.80% -4.83% -4.11% -4.46% -37.49% -17.36%
Tax Burden Percent		 48.89% 93.45% 109.08% 150.59% 193.33% 99.03% 111.93% 102.68% 96.47% 248.17% 208.90%
Interest Burden Percent		 56.25% 46.64% 329.38% 32.44% -523.18% 241.64% 184.69% 151.14% 170.63% 111.76% 141.45%
Effective Tax Rate		 51.11% 6.55% 0.00% -50.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 4.60% 6.45% 0.33% 5.59% 0.26% -3.62% -4.73% -2.05% -2.84% -32.37% -12.58%
ROIC Less NNEP Spread (ROIC-NNEP)		 -2.14% 3.45% -65.40% 3.02% -7.34% -6.97% -9.68% -11.93% -12.29% -134.16% -45.06%
Return on Net Nonoperating Assets (RNNOA)		 -0.12% 1.05% -2.29% 1.00% -2.59% -2.35% -3.08% -3.43% -3.52% -34.89% -14.66%
Return on Equity (ROE)		 4.48% 7.50% -1.96% 6.60% -2.33% -5.98% -7.82% -5.48% -6.36% -67.27% -27.24%
Cash Return on Invested Capital (CROIC)		 -62.63% -8.46% -105.42% 3.44% 6.71% 19.54% 14.47% 10.21% 11.05% 29.98% 26.71%
Operating Return on Assets (OROA)		 4.94% 4.43% -1.03% 3.36% 0.45% -1.63% -2.87% -3.56% -3.66% -19.86% -8.77%
Return on Assets (ROA)		 1.36% 1.93% -3.71% 1.64% -4.53% -3.91% -5.93% -5.52% -6.02% -55.07% -25.92%
Return on Common Equity (ROCE)		 4.48% 7.50% -1.96% 6.60% -2.33% -5.98% -7.82% -5.48% -6.36% -67.27% -27.24%
Return on Equity Simple (ROE_SIMPLE)		 -2.92% 0.00% -1.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 3.18 5.63 0.23 5.13 0.22 -3.10 -3.01 -1.82 -2.30 -21 -6.28
NOPAT Margin		 1.34% 2.45% 0.10% 2.16% 0.10% -1.42% -2.02% -0.80% -1.09% -10.07% -3.91%
Net Nonoperating Expense Percent (NNEP)		 6.75% 3.00% 65.73% 2.57% 7.60% 3.35% 4.95% 9.88% 9.45% 101.78% 32.48%
Return On Investment Capital (ROIC_SIMPLE)		 - 1.17% 0.05% 1.12% 0.05% -0.69% -0.66% -0.43% -0.54% -5.72% -2.01%
Cost of Revenue to Revenue		 77.97% 80.16% 79.78% 77.33% 79.19% 80.45% 76.35% 78.53% 79.66% 83.84% 78.27%
SG&A Expenses to Revenue		 11.80% 11.30% 12.72% 13.45% 12.41% 13.12% 17.35% 14.40% 15.03% 14.37% 20.22%
R&D to Revenue		 7.50% 5.92% 7.36% 7.79% 8.25% 8.46% 9.19% 8.21% 6.87% 5.63% 7.09%
Operating Expenses to Revenue		 19.30% 17.22% 20.08% 21.23% 20.66% 21.58% 26.54% 22.61% 21.90% 30.54% 27.31%
Earnings before Interest and Taxes (EBIT)		 7.90 6.94 -1.71 5.70 0.70 -2.56 -3.48 -6.03 -5.69 -28 -9.45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 17 16 7.06 14 9.71 5.93 4.00 1.81 4.07 -19 -3.24
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.02 1.87 1.83 1.63 1.14 0.71 0.50 0.75 0.85 0.90 0.87
Price to Tangible Book Value (P/TBV)		 2.84 2.63 2.57 2.29 1.62 1.01 0.72 1.09 1.23 1.55 1.62
Price to Revenue (P/Rev)		 0.57 0.55 0.52 0.47 0.34 0.19 0.16 0.22 0.24 0.19 0.16
Price to Earnings (P/E)		 0.00 0.00 0.00 238.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.42% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.74 1.64 1.61 1.47 1.11 0.78 0.61 0.80 0.88 1.25 0.91
Enterprise Value to Revenue (EV/Rev)		 0.67 0.66 0.62 0.57 0.43 0.28 0.24 0.29 0.31 0.31 0.23
Enterprise Value to EBITDA (EV/EBITDA)		 15.52 13.83 12.10 9.88 8.44 6.73 5.77 11.56 16.63 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 81.99 55.41 40.31 28.35 34.19 116.61 537.23 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 73.24 71.53 0.00 69.18 56.40 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.96 129.95 26.15 19.49 10.17 5.23 4.04 4.97 6.19 7.88 16.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 42.53 16.10 3.59 3.89 7.35 7.41 3.34 2.75
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.68 0.67 0.71 0.70 0.72 0.82 0.80 0.63 0.68 1.01 1.00
Long-Term Debt to Equity		 0.00 0.66 0.70 0.69 0.72 0.82 0.80 0.63 0.68 1.01 1.00
Financial Leverage		 0.06 0.31 0.03 0.33 0.35 0.34 0.32 0.29 0.29 0.26 0.33
Leverage Ratio		 2.44 2.34 2.43 2.47 2.46 2.44 2.51 2.46 2.48 2.76 2.86
Compound Leverage Factor		 1.37 1.09 8.01 0.80 -12.88 5.90 4.64 3.72 4.23 3.08 4.04
Debt to Total Capital		 40.49% 39.96% 41.48% 41.20% 41.98% 45.11% 44.53% 38.69% 40.52% 50.16% 50.05%
Short-Term Debt to Total Capital		 40.49% 0.44% 0.44% 0.45% 0.00% 0.00% 0.00% 0.00% 0.22% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 39.51% 41.04% 40.75% 41.98% 45.11% 44.53% 38.69% 40.30% 50.16% 50.05%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 59.51% 60.04% 58.52% 58.80% 58.02% 54.89% 55.47% 61.31% 59.48% 49.84% 49.95%
Debt to EBITDA		 4.40 4.12 3.91 3.51 4.16 5.43 5.96 7.41 10.35 -21.22 -9.92
Net Debt to EBITDA		 2.45 2.23 1.98 1.71 1.87 2.05 2.04 2.72 3.73 -12.40 -4.04
Long-Term Debt to EBITDA		 0.00 4.07 3.87 3.47 4.16 5.43 5.96 7.41 10.29 -21.22 -9.92
Debt to NOPAT		 20.76 21.31 -1.62 24.55 27.84 -755.82 -57.84 -23.61 -18.06 -6.70 -5.16
Net Debt to NOPAT		 11.58 11.53 -0.82 11.96 12.49 -285.65 -19.79 -8.67 -6.50 -3.91 -2.10
Long-Term Debt to NOPAT		 0.00 21.07 -1.60 24.28 27.84 -755.82 -57.84 -23.61 -17.96 -6.70 -5.16
Altman Z-Score		 2.79 3.14 3.04 2.94 2.70 2.59 2.23 2.40 2.42 2.30 2.42
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.14 2.41 2.39 2.27 2.44 2.58 2.39 2.14 2.13 2.30 2.02
Quick Ratio		 0.56 1.16 1.21 1.13 1.25 1.40 1.35 1.16 1.15 0.90 1.22
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -183 -35 -180 9.97 18 67 51 40 44 87 96
Operating Cash Flow to CapEx		 -9.38% 107.36% 159.42% 123.90% 178.09% 371.18% 168.49% 340.59% 58.24% 143.90% -1,894.40%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.49 1.47 1.45 1.40 1.37 1.40 1.23 1.34 1.35 1.47 1.49
Accounts Receivable Turnover		 5.68 6.01 5.63 5.34 5.48 5.97 5.00 5.30 5.61 7.60 5.88
Inventory Turnover		 4.65 4.55 4.40 4.20 4.05 4.24 3.87 4.30 4.31 5.35 5.34
Fixed Asset Turnover		 9.37 9.09 9.11 9.02 8.75 8.74 7.96 8.64 8.58 10.74 10.95
Accounts Payable Turnover		 6.54 6.97 6.36 6.08 6.35 7.36 6.23 6.50 6.94 9.46 7.00
Days Sales Outstanding (DSO)		 64.24 60.73 64.85 68.35 66.63 61.14 72.93 68.87 65.04 48.06 62.05
Days Inventory Outstanding (DIO)		 78.50 80.19 82.97 86.87 90.22 86.07 94.28 84.80 84.69 68.16 68.37
Days Payable Outstanding (DPO)		 55.81 52.34 57.41 60.00 57.51 49.60 58.63 56.11 52.59 38.58 52.12
Cash Conversion Cycle (CCC)		 86.92 88.58 90.40 95.22 99.35 97.61 108.59 97.56 97.13 77.64 78.30
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 377 391 377 363 359 321 323 321 313 214 220
Invested Capital Turnover		 3.44 2.63 3.40 2.58 2.50 2.55 2.34 2.57 2.60 3.22 3.22
Increase / (Decrease) in Invested Capital		 187 40 181 -4.84 -18 -70 -54 -42 -47 -107 -103
Enterprise Value (EV)		 656 643 608 534 398 250 197 256 275 268 199
Market Capitalization		 552 539 508 442 310 174 127 196 213 162 135
Book Value per Share		 $9.93 $10.44 $10.06 $9.77 $9.80 $8.86 $9.14 $9.36 $8.97 $6.42 $5.57
Tangible Book Value per Share		 $7.06 $7.45 $7.17 $6.96 $6.92 $6.23 $6.40 $6.48 $6.17 $3.73 $2.99
Total Capital		 459 479 474 460 468 447 456 425 422 361 313
Total Debt		 186 191 196 189 196 202 203 164 171 181 156
Total Long-Term Debt		 0.00 189 194 187 196 202 203 164 170 181 156
Net Debt		 104 104 99 92 88 76 70 60 62 106 64
Capital Expenditures (CapEx)		 10 9.89 5.71 6.98 6.04 5.18 5.99 3.14 6.19 6.14 0.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 204 212 205 196 190 166 164 160 151 151 105
Debt-free Net Working Capital (DFNWC)		 240 253 253 238 245 238 243 209 205 204 175
Net Working Capital (NWC)		 55 251 251 236 245 238 243 209 204 204 175
Net Nonoperating Expense (NNE)		 1.01 2.60 6.36 2.34 7.29 3.01 4.18 7.54 7.08 56 22
Net Nonoperating Obligations (NNO)		 104 104 99 92 88 76 70 60 62 34 64
Total Depreciation and Amortization (D&A)		 8.71 9.00 8.77 8.73 9.01 8.49 7.48 7.84 9.77 8.60 6.21
Debt-free, Cash-free Net Working Capital to Revenue		 20.84% 21.77% 21.03% 20.73% 20.70% 18.24% 20.01% 18.17% 17.30% 17.56% 12.01%
Debt-free Net Working Capital to Revenue		 24.60% 25.95% 26.00% 25.19% 26.59% 26.15% 29.68% 23.84% 23.47% 23.72% 20.09%
Net Working Capital to Revenue		 5.58% 25.74% 25.79% 24.97% 26.59% 26.15% 29.68% 23.84% 23.37% 23.72% 20.09%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.08 $0.11 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00)
Adjusted Weighted Average Basic Shares Outstanding		 27.48M 27.44M 27.53M 27.61M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M
Adjusted Diluted Earnings per Share		 $0.08 $0.11 ($0.22) $0.10 ($0.26) ($0.22) ($0.26) ($0.34) ($0.34) ($2.76) ($1.00)
Adjusted Weighted Average Diluted Shares Outstanding		 27.73M 27.44M 27.53M 27.85M 27.62M 27.60M 27.68M 27.79M 27.86M 27.80M 27.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.55M 27.55M 27.67M 27.68M 27.69M 27.70M 27.85M 28.01M 28.02M 28.02M 28.24M
Normalized Net Operating Profit after Tax (NOPAT)		 4.56 5.63 0.23 2.38 0.22 -3.10 -3.01 -1.82 -2.30 -21 -6.28
Normalized NOPAT Margin		 1.91% 2.45% 0.10% 1.01% 0.10% -1.42% -2.02% -0.80% -1.09% -10.07% -3.91%
Pre Tax Income Margin		 1.86% 1.41% -2.35% 0.78% -1.71% -2.83% -4.31% -4.00% -4.62% -15.11% -8.31%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Stoneridge (NYSE: SRI) is showing a mixed but improving operating picture in early 2026, after a very weak 2025. Revenue fell sharply year over year, but the company posted a much smaller loss than in late 2025, and cash generation improved meaningfully from the prior quarter. That said, profitability remains negative, leverage is still meaningful, and the balance sheet includes a large amount of working-capital assets and debt that investors should watch closely.

  • Q1 2026 operating cash flow improved to a $11.5 million cash outflow from a $8.8 million inflow in Q4 2025, but it was still much better than the weak 2025 quarters that burned cash or barely broke even.
  • The company generated $58.4 million in investing cash inflows in Q1 2026, largely because of $59.0 million in divestitures, which boosted liquidity.
  • Cash and equivalents rose to $70.5 million at the end of Q1 2026, up from $53.0 million at the end of Q3 2025 and $49.8 million at the end of Q2 2025.
  • Net loss improved significantly versus Q4 2025, falling to $27.9 million from $76.9 million in the prior quarter.
  • The company’s quarterly revenue of $160.8 million was less than recent 2025 quarters, but cost of revenue also came down, helping gross profit stay positive at $35.0 million.
  • R&D and SG&A remain substantial, with $11.4 million in R&D and $32.5 million in SG&A in Q1 2026, indicating the company is still investing heavily in operations.
  • Accounts receivable of $140.2 million and inventories of $111.3 million remain large relative to quarterly revenue, suggesting working-capital demands are still significant.
  • Long-term debt stood at $156.5 million at Q1 2026, down from $170.2 million at Q3 2025, showing some debt reduction progress.
  • Revenue dropped to $160.8 million in Q1 2026 from $205.2 million in Q4 2025 and $210.3 million in Q3 2025, signaling a softer top line.
  • Stoneridge still reported a net loss of $27.9 million in Q1 2026, or about $1.00 per share, so profitability remains a challenge.
  • Operating income was still negative at $9.0 million, meaning core operations are not yet consistently covering overhead.
  • Total liabilities of $355.8 million remain high versus $156.2 million of common equity, leaving the capital structure leveraged.
  • The company paid $4.4 million in cash interest in Q1 2026, reinforcing that debt service continues to pressure earnings and cash flow.

Longer-term trend: Compared with 2024, Stoneridge’s 2025 results deteriorated sharply, with several quarters of losses and uneven cash flow. The latest quarter suggests some stabilization, but the business is still far from a consistent earnings recovery. Investors will likely want to see sustained revenue growth, positive operating income, and steadier free cash flow before calling the turnaround complete.

07/06/26 03:17 AM ETAI Generated. May Contain Errors.

Stoneridge Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Stoneridge's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Stoneridge's net income appears to be on a downward trend, with a most recent value of -$102.84 million in 2025, falling from $20.57 million in 2015. The previous period was -$16.52 million in 2024. View Stoneridge's forecast to see where analysts expect Stoneridge to go next.

Stoneridge's total operating income in 2025 was -$38.61 million, based on the following breakdown:
  • Total Gross Profit: $171.15 million
  • Total Operating Expenses: $209.76 million

Over the last 10 years, Stoneridge's total revenue changed from $644.81 million in 2015 to $861.26 million in 2025, a change of 33.6%.

Stoneridge's total liabilities were at $371.34 million at the end of 2025, a 1.3% decrease from 2024, and a 44.0% increase since 2015.

In the past 10 years, Stoneridge's cash and equivalents has ranged from $40.84 million in 2023 to $85.55 million in 2021, and is currently $53.06 million as of their latest financial filing in 2025.

Over the last 10 years, Stoneridge's book value per share changed from 3.34 in 2015 to 6.42 in 2025, a change of 92.3%.


Related Companies

Financial statements for NYSE:SRI last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Buy the “unseen winner of the AI race” before July 22
Marc Chaikin - the analyst who called Nvidia before a 45,000% surge - says one overlooked AI stock could split...
Chaikin Analytics | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Elon Musk on His New Invention: “An Infinite Money Glitch.”
Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's ...
Brownstone Research | Sponsoredtc pixel
They proved it worked in '76. Then buried it.
In 1976, Chevron, Unocal, and Texaco each confirmed the same energy technology worked - no fuel costs, no carb...
Behind the Markets | Sponsoredtc pixel